Wanjing J. Ding

No. 1 Zheda Road
Zhoushan, 316021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.

Design, Synthesis, and Evaluation of a Potent and Selective ROCK2 Inhibitor for Atopic Dermatitis Treatment.

Journal: Journal of medicinal chemistry

Published: January 23, 2026

Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.

Discovery of an orally bioavailable pyridone-based BRD4 inhibitor with potent antitumor efficacy in colorectal cancer.

Journal: European journal of medicinal chemistry

Published: November 12, 2025

Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009].

Corrigendum to "Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury" [Eur. J. Pharmacol. 1004 (2025) 178009].

Journal: European journal of pharmacology

Published: August 25, 2025

DGMM: A Deep Learning-Genetic Algorithm Framework for Efficient Lead Optimization in Drug Discovery.

DGMM: A Deep Learning-Genetic Algorithm Framework for Efficient Lead Optimization in Drug Discovery.

Journal: Journal of chemical information and modeling

Published: July 30, 2025

A novel small molecule inhibitor targeting KHSRP methylation suppresses colon cancer progression.

A novel small molecule inhibitor targeting KHSRP methylation suppresses colon cancer progression.

Journal: Acta pharmaceutica Sinica. B

Published: June 10, 2025

KHSRP protects colorectal cancer cells against ferroptosis by regulating GPX4 expression through interaction with hnRNPM.

KHSRP protects colorectal cancer cells against ferroptosis by regulating GPX4 expression through interaction with hnRNPM.

Journal: Experimental cell research

Published: May 08, 2025

Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury.

Degradation of NLRP3 by selective ROCK2 inhibitor alleviates acute lung injury.

Journal: European journal of pharmacology

Published: April 21, 2025

Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide-1 Receptor Agonists with Reduced hERG Inhibitory Activities.

Discovery of New Difluorocyclobutyl Derivatives as Effective Glucagon-Like Peptide-1 Receptor Agonists with Reduced hERG Inhibitory Activities.

Journal: Journal of medicinal chemistry

Published: April 01, 2025

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.

Journal: Journal of medicinal chemistry

Published: November 11, 2024

Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer.

Natural Derivatives of Selective HDAC8 Inhibitors with Potent in Vivo Antitumor Efficacy against Breast Cancer.

Journal: Journal of medicinal chemistry

Published: August 07, 2024

Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer.

Bipyridine Derivatives as NOP2/Sun RNA Methyltransferase 3 Inhibitors for the Treatment of Colorectal Cancer.

Journal: Journal of medicinal chemistry

Published: July 26, 2024

Design, Synthesis, and Biological Evaluation of an Orally Bioavailable, Potent, and Selective ROCK2 Inhibitor for Psoriasis Treatment.

Design, Synthesis, and Biological Evaluation of an Orally Bioavailable, Potent, and Selective ROCK2 Inhibitor for Psoriasis Treatment.

Journal: Journal of medicinal chemistry

Published: November 09, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026